Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Pancreatic Cancer Clinical Trials in Maryland | 345 Studies

Clinical Trials Pancreatic CancerMaryland

Pancreatic Cancer Clinical Trials in Maryland

Find 345 clinical trials for pancreatic cancer near Maryland. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 345 trials

Active not recruitingTesting the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerThis phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer…NCT04340141·Birmingham, Alabama and 452 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingPalbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers.NCT05554367·Birmingham, Alabama and 264 others

CompletedQUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerThe purpose of the phase 2 component of this study is to determine if giving the immune molecule NPC-1C to individuals who have cancer of the pancreas or gastrointestinal tract…NCT01040000·Tampa, Florida and 5 others

CompletedA Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)Multicenter, open-label, phase 1, cohort dose escalation study to determine the Maximum Tolerated Dose (MTD) of OSI-906 in combination with erlotinibNCT00739453·Aurora, Colorado and 3 others

CompletedScreening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)CAPS4 is a study at Johns Hopkins Hospital to study the diagnosis and long-term outcomes of screening patients with an increased inherited risk for pancreatic cancer.NCT00714701·Baltimore, Maryland

CompletedA Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabThis is a phase II clinical and pharmacokinetic study of suppression of human antimouse (HAMA) and antitoxin antibodies (HATA) to immunotoxin LMB-1 by Rituximab (anti-CD20).NCT00001805·Bethesda, Maryland

Active not recruitingComparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialThis phase II trial compares the effect of combination therapy with capecitabine and temozolomide to lutetium Lu 177 dotatate for the treatment of pancreatic neuroendocrine tumors…NCT05247905·Fairbanks, Alaska and 170 others

RecruitingKRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerPhase 1b study evaluating the efficacy and immune response to a synthetic long peptide mutant KRAS vaccine (SPL mKRASvax) combined with Balstilimab and Botensilimab for…NCT06411691·Baltimore, Maryland

CompletedPhase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic AdenocarcinomaThis multi-institutional trial aims to evaluate the potential benefit and side effects of adding fractionated stereotactic body radiotherapy/surgery (SBRT) before and after…NCT01146054·Stanford, California and 2 others

Active not recruitingPlatform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the PancreasThis platform trial will evaluate various immunotherapy combinations given in the neo-adjuvant and adjuvant setting in patients with surgically resectable pancreatic ductal…NCT02451982·Baltimore, Maryland

TerminatedA Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic CancerThe primary objective of the study is to assess the activity of TPI 287 as single agent therapy for patients with advanced, unresectable pancreatic cancer after failure of…NCT00553813·Rancho Mirage, California and 3 others

RecruitingLOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer CachexiaThis study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic…NCT06073431·Fort Smith, Arkansas and 224 others

CompletedA Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid TumorsThe purpose of this study is to evaluate the tolerability and safety profile of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab in…NCT03565445·New Haven, Connecticut and 41 others

TerminatedA Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal AdenocarcinomaThe purpose of this study is to compare the efficacy and safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) combined with nab-paclitaxel plus gemcitabine (PAG…NCT02715804·Mobile, Alabama and 216 others

UnknownPEN-866 in Patients With Advanced Solid MalignanciesProtocol PEN-866-001 is an open-label, multi-center, first-in-human Phase 1/2a study evaluating PEN-866 in patients with advanced solid malignancies whose disease has progressed…NCT03221400·Springdale, Arkansas and 15 others

RecruitingA Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesATLAS-101 is a Phase I/II clinical trial of AMXI-5001 in adult participants with advanced malignancies who have previously failed other therapies. The study has two phases.NCT04503265·Los Angeles, California and 3 others

TerminatedPhase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic CancerThe is a double-blind, randomized phase 3 study of 90Y-clivatuzumab tetraxetan with low-dose gemcitabine, versus placebo and low-dose gemcitabine in metastatic pancreatic cancer…NCT01956812·Gilbert, Arizona and 63 others

RecruitingTesting Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerThis phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have…NCT06958328·Gilbert, Arizona and 332 others

CompletedChemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerThis pilot clinical trial studies combination chemotherapy and radiation therapy before surgery followed by gemcitabine hydrochloride in treating patients with pancreatic cancer.NCT01821612·La Jolla, California and 13 others

CompletedHedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasThis is an open-label, single arm, multi-center, Phase II trial to evaluate the progression free survival in patients with metastatic adenocarcinoma of the pancreas treated with a…NCT01088815·Scottsdale, Arizona and 2 others

PreviousPage 10 of 18Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia